stoxline Quote Chart Rank Option Currency Glossary
  
Cosmos Health Inc. (COSM)
0.4501  -0.044 (-8.89%)    07-15 15:58
Open: 0.474
High: 0.4866
Volume: 196,561
  
Pre. Close: 0.494
Low: 0.43
Market Cap: 13(M)
Technical analysis
2025-07-15 3:46:18 PM
Short term     
Mid term     
Targets 6-month :  0.58 1-year :  0.68
Resists First :  0.5 Second :  0.58
Pivot price 0.44
Supports First :  0.43 Second :  0.38
MAs MA(5) :  0.47 MA(20) :  0.44
MA(100) :  0.45 MA(250) :  0.69
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  82.3 D(3) :  86.3
RSI RSI(14): 50.9
52-week High :  1.58 Low :  0.28
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ COSM ] has closed below upper band by 41.5%. Bollinger Bands are 16.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.5 - 0.5 0.5 - 0.5
Low: 0.47 - 0.48 0.48 - 0.48
Close: 0.49 - 0.49 0.49 - 0.5
Company Description

Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Headline News

Tue, 24 Jun 2025
Cosmos Health's Strategic Manufacturing Shift: A Shield Against Tariffs and a Path to Profitability - AInvest

Tue, 24 Jun 2025
Cosmos Health Makes Bold US Entry: Strategic Manufacturing Deal Eliminates Tariff Risks - Stock Titan

Tue, 24 Jun 2025
Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech - GlobeNewswire

Tue, 06 May 2025
Cosmos Health Escapes Immediate Delisting Risk: Nasdaq Grants Critical 180-Day Extension - Stock Titan

Tue, 06 May 2025
Cosmos Health Inc. Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Nasdaq

Wed, 30 Apr 2025
Cosmos Health CEO boosts stake with $526,000 share purchase - Investing.com

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 29 (M)
Shares Float 18 (M)
Held by Insiders 31 (%)
Held by Institutions 9.4 (%)
Shares Short 493 (K)
Shares Short P.Month 437 (K)
Stock Financials
EPS -1.1
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.94
Profit Margin -28.3 %
Operating Margin -6.1 %
Return on Assets (ttm) -14.9 %
Return on Equity (ttm) -50.1 %
Qtrly Rev. Growth -6 %
Gross Profit (p.s.) 0.17
Sales Per Share 1.83
EBITDA (p.s.) -0.45
Qtrly Earnings Growth 0 %
Operating Cash Flow -4 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio -0.42
PEG Ratio 0
Price to Book value 0.47
Price to Sales 0.24
Price to Cash Flow -2.95
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android